Dyax Corp. (Dyax) is a biopharmaceutical company focused on the discovery, development and commercialization of biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. The Company's lead product, DX-88, has been approved under the brand name KALBITOR (ecallantide) by the United States Food and Drug Administration (FDA) for treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. The Company commercializes KALBITOR on its own in the United States. In addition to its approved commercial use for HAE in the United States, the Company is also developing DX-88 through collaborations in other indications. These include use of DX-88 for the reduction of blood loss during surgery in collaboration with Cubist Pharmaceuticals (Cubist), and for treatment of retinal diseases in collaboration with Fovea Pharmaceuticals (Fovea), which was acquired by sanofi-aventis during the year ended December 31, 2009.

Beijing Midas Medical Equipment Co., Ltd., established on 2002-04-17, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of Class II Medical Devices;Production of Class I Medical Devices;Sales of Class I Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Special Equipment Repair;software development;Import and export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

CorMatrix Cardiovascular is a privately held medical device company that is dedicated to developing and delivering innovative biomaterial devices that harness the body’s own innate ability to repair damaged heart tissue. The company is currently researching, developing, and commercializing a platform technology, known as CorMatrix ECM, for a variety of cardiovascular indications. Incorporated in December of 2001, CorMatrix was co-founded by David Camp, an entrepreneurial executive in the cardiovascular medical device field, and Robert G. Matheny, MD, a cardiothoracic surgeon and co-inventor on several patents related to extracellular matrix (ECM) technology. Dr. Matheny’s interest and experience with these unique materials began at Purdue University in the 1990s while he was a private practice cardiac surgeon in Indianapolis. Realizing the potential of extracellular matrix materials for cardiovascular surgery, he further increased his study and preclinical work in matrix materials and tissue repair.

Fu Wai Hospital, founded in 1956.

Guizhou Provincial People's Hospital is a private company headquartered in Guiyang, China, that provides medical services.

The First Hospital of Jilin University, a subsidiary of Jilin University, is a Chinese company located in Changchun. The firm owns and operates hospital.

Xiangyang Central Hospital is a private company headquartered in Xiangyang, China. The firm owns and operates general medical and surgical hospital.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Med MicroPort (Tianjin) Medical Devices Co., Ltd., established on 2018-07-25, Business scope includes production,research and development,Sales of medical devices(Carry out business activities with a license),technical consulting,Technical Services,technology transfer,Technology Promotion,Technical Training,Office Supplies;Organize cultural and artistic exchange activities;Conference Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The First Affiliated Hospital of Xiamen University, a subsidiary of Xiamen University, is a company headquartered in Xiamen, China, that owns and operates general hospitals.

Breethe is a medical device company that develops a compact artificial lung for patients with acute and chronic lung problems. Breethe's system, called the OXY-1 System, is designed to remove carbon dioxide and add oxygen to a patient's blood, much like a working human lung would. The tech eliminates the need for bulky oxygen tanks and allows patients in need of ECMO therapy to move around more easily. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

The Nanjing General Hospital of People's Liberation Army (NGH; Chinese: 中国人民解放军南京总医院), formerly Nanjing General Hospital of Nanjing Military Command (Chinese: 中国人民解放军南京军区南京总医院), or Nanjing General Hospital, The Military General Hospital, is also known as Jinling Hospital (formally Jinling Hospital of the Medical School of Nanjing University) which used to be Central Hospital. NGH is located at 305 Zhongshan East Road, Nanjing, Jiangsu Province, China. It is a large comprehensive teaching hospital integrating medical services with teaching and research.

Manufactures, marketes and imports, exports pharmaceutical drugs

Kaifeng Central Hospital is a private company headquartered in Kaifeng, China. The firm provides healthcare services.